Editorial: Innate immune cell therapy of cancer

Natasha Khatwani; Rizwan Romee; Asha B Pillai

doi:10.3389/fimmu.2022.1004415

Editorial: Innate immune cell therapy of cancer

Front Immunol. 2022 Aug 19:13:1004415. doi: 10.3389/fimmu.2022.1004415. eCollection 2022.

Authors

Natasha Khatwani^{1

2

3

4}, Rizwan Romee⁵, Asha B Pillai^{1

2

3

4}

Affiliations

¹ Department of Pediatrics, Stuart M. Miller School of Medicine, Miami, FL, United States.
² Department of Microbiology & Immunology, Stuart M. Miller School of Medicine, Miami, FL, United States.
³ Sheila and David Fuente Program in Cancer Biology, University of Miami, Miami, FL, United States.
⁴ Program in Tumor Biology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, United States.
⁵ Division of Hematologic Neoplasia, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.

No abstract available

Keywords: CAR-NK cell; CAR-gamma delta T cells; gamma-delta (γ/δ) T lymphocytes; immunotherapy; innate immunity; macrophage; natural killer (Nk) cell; natural killer T (NKT) cells.

Publication types

Editorial

MeSH terms

Cell- and Tissue-Based Therapy
Humans
Immunity, Innate
Neoplasms* / therapy
T-Lymphocytes